Cetera Investment Advisers’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Cetera Investment Advisers’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$184K	Buy	+11,995	New	+$173K	﹤0.01%	4515

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Cetera Investment Advisers's BMEZ Position: Q2 2026 in Review

Cetera Investment Advisers opened a new position in BlackRock Health Sciences Trust II (BMEZ) in Q2 2026: 11,995 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #4515 among its holdings.

88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

Cetera Investment Advisers held 11,995 shares of BlackRock Health Sciences Trust II worth $184K as of Q2 2026.
BlackRock Health Sciences Trust II was a new Cetera Investment Advisers position in Q2 2026.
BlackRock Health Sciences Trust II made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4515 holding.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.